Area of research
Molecular Biology · Pathology and Forensic Medicine
Research interest
Research focused on Cancer and Renal cell carcinoma, with related work in Cancer research, Immunohistochemistry, Proteomics. Notable publications include '14-3-3 zeta as novel molecular target for cancer therapy', 'Quantitative Proteomic Analysis in Metastatic Renal Cell Carcinoma Reveals a Unique Set of Proteins with Potential Prognostic Significance', and 'S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia'.
Identification of 14‐3‐3zeta associated protein networks in oral cancer
The biological basis of degenerative disc disease: proteomic and biomechanical analysis of the canine intervertebral disc
Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer
S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia
Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme
Relative quantification of protein expression in metastatic renal cell carcinoma using iTRAQ LC-MS/MS analysis reveals galectin-1 as a potential prognostic marker and therapeutic target.
14-3-3 zeta as novel molecular target for cancer therapy
Quantitative Proteomic Analysis in Metastatic Renal Cell Carcinoma Reveals a Unique Set of Proteins with Potential Prognostic Significance
Potential Molecular Targets: From Bench to Bedside